Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages

  Wolf, Armin ^a   Thurau, Stephan ^a   Kook, Daniel ^a   Hoeing, Anna ^a   Priglinger, Siegfried ^a   Kampik, Anselm ^a   Haritoglou, Christos ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

CASE REPORT; CHORIORETINITIS; CONTRACEPTION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LETTER; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHORIORETINITIS; CHOROIDAL NEOVASCULARIZATION; HUMANS; INJECTIONS, INTRAOCULAR; VITREOUS BODY;

EID: 78349259726     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01681.x     Document Type: Letter

References (6)

1. Adán A, Mateo C, Navarro R, Bitrian E, &, Casaroli-Marano RP, (2007): Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularization. Retina 27: 1180 - 1186. (Pubitemid 350211522)
2. Croll SD, Goodman JH, &, Scharfman HE, (2004b): Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. Adv Exp Med Biol 548: 57 - 68.
3. Croll SD, Ransohoff RM, Cai N, etal. (2004a): VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 187: 388 - 402.
4. Kurup S, Lew J, Byrnes G, Yeh S, Nussenblatt R, &, Levy-Clarke G, (2009): Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization. Acta Ophthalmol 87: 349 - 52.
5. Pieramici DJ, Avery RL, Castellarin AA, Nasir MA, &, Rabena M, (2006): Case of anterior uveitis after intravitreal injection of bevacizumab. Retina 26: 841 - 842.
6. Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A, &, Ulbig M, (2008): Anti-VEGF treatment for retinal angiomatous proliferation. Ophthalmologe 105: 845 - 51.